Scientific Session
Systemic Lupus Erythematosus (SLE)
David Karp, MD, PhD, MACR
UT Southwestern Medical Center
Dallas, Texas, United States
Disclosure(s): Ampel: Consultant (Terminated, August 11, 2023); Biogen: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Caribou: Consultant (Terminated, May 6, 2025); Celgene: Grant/Research Support (Terminated, February 7, 2022); Eli Lilly: Grant/Research Support (Terminated, September 12, 2023); Novartis: Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing); UCB: Grant/Research Support (Terminated, October 18, 2024); Zura: Consultant (Ongoing)